Crinetics Pharmaceuticals, Inc. Balance Sheet
CRNX / Health Care|10 years of annual SEC 10-K data (FY2016-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
Crinetics Pharmaceuticals, Inc. had $1.1B in total assets and $992M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $101.5M | $264.5M | $54.9M | $32.7M | $200.7M | $40.3M | $45.0M | $45.0M | $14.2M | - |
| Accounts Receivable | $592.0K | - | - | - | - | - | - | - | - | - |
| Inventory | $2.0M | - | - | - | - | - | - | - | - | - |
| Current Assets | $1.0B | $1.4B | $574.2M | $345.2M | $344.7M | $177.5M | $123.3M | $166.7M | $15.2M | - |
| PP&E (Net) | $14.3M | $12.1M | $10.9M | $3.5M | $2.8M | $3.2M | $3.9M | $4.2M | $400.0K | - |
| Total Assets | $1.1B | $1.4B | $635.4M | $352.2M | $351.0M | $183.4M | $130.4M | $171.4M | $15.6M | - |
| Current Liabilities | $85.1M | $59.7M | $43.9M | $27.7M | $16.0M | $10.5M | $8.3M | $7.9M | $897.0K | - |
| Shareholders' Equity | $992.1M | $1.3B | $539.1M | $316.3M | $331.9M | $160.2M | -$15.0M | -$6.2M | -$15.0M | -$6.2M |